$NRSN

2 stories mentioning NRSN

Every FINWIRES story that references NRSN, newest first.

Sector Update: Healthcare Stocks Rise Tuesday Afternoon

Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 1.1% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.8%.The iShares Biotechnology ETF (IBB) rose 0.2%.In corporate news, GSK (GSK) said it signed a definitive agreement Tuesday to acquire Nuvalent (NUVL) for $10.6 billion in cash. GSK shares rose 0.9%, and Nuvalent surged 39%.Eli Lilly (LLY) entered into a collaboration and licensing agreement worth over $1 billion with Swedish pharmaceutical company AlzeCure Pharma for global rights to its investigative candidate for Alzheimer's disease. Lilly shares were down 0.5%.NeuroSense Therapeutics (NRSN) shares added 1% after it said Tuesday that it has been issued a patent by the Japan Patent Office for PrimeC, its lead drug candidate to treat amyotrophic lateral sclerosis.

$GSK$LLY$NRSN$NUVL

Wire47d ago

NeuroSense Therapeutics Prices $600,000 Private Placement of Shares

NeuroSense Therapeutics (NRSN) said Tuesday it will sell 750,000 shares at $0.80 apiece in a private placement for gross proceeds of $600,000.The private placement, expected to close next week, was led by Chief Executive Alon Ben-Noon, Chief Financial Officer Or Eisenberg, and an existing shareholder, each committing $200,000, the company said.NeuroSense said it plans to use the proceeds from the offering for general corporate purposes as it approaches clinical and regulatory milestones.Price: $0.80, Change: $+0.05, Percent Change: +6.60%

$NRSN